Provectus Biopharmaceuticals Price on May 26, 2023
| PVCTDelisted Stock | USD 0.11 0.00 0.00% |
If you're considering investing in Provectus OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Provectus Biopharmaceutica stands at 0.11, as last reported on the 3rd of January, with the highest price reaching 0.11 and the lowest price hitting 0.11 during the day. We have found four technical indicators for Provectus Biopharmaceutica, which you can use to evaluate the volatility of the company. Please check Provectus Biopharmaceutica's Rate Of Daily Change of 1.0, day typical price of 0.11, and Relative Strength Index of 42.45 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Provectus OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Provectus |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PVCT |
Based on monthly moving average Provectus Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Provectus Biopharmaceutica by adding Provectus Biopharmaceutica to a well-diversified portfolio.
Provectus Biopharmaceutica Valuation on May 26, 2023
It is possible to determine the worth of Provectus Biopharmaceutica on a given historical date. On May 26, 2023 Provectus was worth 0.13 at the beginning of the trading date compared to the closed value of 0.13. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Provectus Biopharmaceutica otc stock. Still, in general, we apply an absolute valuation method to find Provectus Biopharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Provectus Biopharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Provectus Biopharmaceutica's related companies.
| Open | High | Low | Close | Volume | |
| 0.13 | 0.13 | 0.13 | 0.13 | 44,910 | |
05/26/2023 | 0.13 | 0.13 | 0.13 | 0.13 | 75,996 |
| 0.13 | 0.14 | 0.13 | 0.14 | 210,992 |
| Backtest Provectus Biopharmaceutica | | | Provectus Biopharmaceutica History | | | Provectus Biopharmaceutica Valuation | Previous | Next |
Provectus Biopharmaceutica Trading Date Momentum on May 26, 2023
| On May 30 2023 Provectus Biopharmaceuticals was traded for 0.14 at the closing time. The top price for the day was 0.14 and the lowest listed price was 0.13 . The trading volume for the day was 211 K. The trading history from May 30, 2023 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 7.69% . The trading delta at closing time against the current closing price is 0.00% . |
Provectus Biopharmaceutica Fundamentals Correlations and Trends
By evaluating Provectus Biopharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Provectus Biopharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Provectus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Provectus Biopharmaceutica OTC Stock history
Provectus Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Provectus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Provectus Biopharmaceutica will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Provectus Biopharmaceutica stock prices may prove useful in developing a viable investing in Provectus Biopharmaceutica
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. Provectus Biopharmaceuticals, Inc. was incorporated in 2002 and is based in Knoxville, Tennessee. Provectus Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Provectus Biopharmaceutica OTC Stock Technical Analysis
Provectus Biopharmaceutica technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Provectus Biopharmaceutica Period Price Range
Low | January 3, 2025
| High |
0.00 | 0.00 |
Provectus Biopharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Provectus Biopharmaceutica January 3, 2025 Market Strength
Market strength indicators help investors to evaluate how Provectus Biopharmaceutica otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Provectus Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Provectus Biopharmaceutica otc stock market strength indicators, traders can identify Provectus Biopharmaceuticals entry and exit signals to maximize returns
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Provectus Biopharmaceutica information on this page should be used as a complementary analysis to other Provectus Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Provectus OTC Stock
If you are still planning to invest in Provectus Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provectus Biopharmaceutica's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |